The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Point of Care Diagnostic and Testing-Global Market Insights and Sales Trends 2024
Synopsis
The global Point of Care Diagnostic and Testing market size is expected to reach US$ 91310 million by 2029, growing at a CAGR of 10.8% from 2023 to 2029. The market is mainly driven by the significant applications of Point of Care Diagnostic and Testing in various end use industries. The expanding demands from the Hospitals, Clinics, Home and Others, are propelling Point of Care Diagnostic and Testing market. Device, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Consumables segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point of Care Diagnostic and Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point of Care Diagnostic and Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point of Care Diagnostic and Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point of Care Diagnostic and Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point of Care Diagnostic and Testing covered in this report include F. Hoffmann-La Roche, Qiagen, Danaher, Becton Dickinson and Company, Biomerieux, Siemens Healthcare, Zoetis, Abbott and Bayer, etc.
The global Point of Care Diagnostic and Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F. Hoffmann-La Roche
Qiagen
Danaher
Becton Dickinson and Company
Biomerieux
Siemens Healthcare
Zoetis
Abbott
Bayer
Johnson and Johnson
Nova Biomedical
Trividia Health
Quidel Corporation
Trinity Biotech
Sekisui Diagnostics
Orasure Technologies
Nipro
Spectral Medical
Global Point of Care Diagnostic and Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point of Care Diagnostic and Testing market, Segment by Type:
Device
Consumables
Others
Global Point of Care Diagnostic and Testing market, by Application
Hospitals
Clinics
Home
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point of Care Diagnostic and Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Point of Care Diagnostic and Testing market size is expected to reach US$ 91310 million by 2029, growing at a CAGR of 10.8% from 2023 to 2029. The market is mainly driven by the significant applications of Point of Care Diagnostic and Testing in various end use industries. The expanding demands from the Hospitals, Clinics, Home and Others, are propelling Point of Care Diagnostic and Testing market. Device, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Consumables segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point of Care Diagnostic and Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point of Care Diagnostic and Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point of Care Diagnostic and Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point of Care Diagnostic and Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point of Care Diagnostic and Testing covered in this report include F. Hoffmann-La Roche, Qiagen, Danaher, Becton Dickinson and Company, Biomerieux, Siemens Healthcare, Zoetis, Abbott and Bayer, etc.
The global Point of Care Diagnostic and Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F. Hoffmann-La Roche
Qiagen
Danaher
Becton Dickinson and Company
Biomerieux
Siemens Healthcare
Zoetis
Abbott
Bayer
Johnson and Johnson
Nova Biomedical
Trividia Health
Quidel Corporation
Trinity Biotech
Sekisui Diagnostics
Orasure Technologies
Nipro
Spectral Medical
Global Point of Care Diagnostic and Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point of Care Diagnostic and Testing market, Segment by Type:
Device
Consumables
Others
Global Point of Care Diagnostic and Testing market, by Application
Hospitals
Clinics
Home
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point of Care Diagnostic and Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Point of Care Diagnostic and Testing
1.1 Point of Care Diagnostic and Testing Market Overview
1.1.1 Point of Care Diagnostic and Testing Product Scope
1.1.2 Point of Care Diagnostic and Testing Market Status and Outlook
1.2 Global Point of Care Diagnostic and Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Point of Care Diagnostic and Testing Market Size by Region (2018-2029)
1.4 Global Point of Care Diagnostic and Testing Historic Market Size by Region (2018-2023)
1.5 Global Point of Care Diagnostic and Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Point of Care Diagnostic and Testing Market Size (2018-2029)
1.6.1 North America Point of Care Diagnostic and Testing Market Size (2018-2029)
1.6.2 Europe Point of Care Diagnostic and Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Point of Care Diagnostic and Testing Market Size (2018-2029)
1.6.4 Latin America Point of Care Diagnostic and Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Point of Care Diagnostic and Testing Market Size (2018-2029)
2 Point of Care Diagnostic and Testing Market by Type
2.1 Introduction
2.1.1 Device
2.1.2 Consumables
2.1.3 Others
2.2 Global Point of Care Diagnostic and Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Point of Care Diagnostic and Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Point of Care Diagnostic and Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Point of Care Diagnostic and Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Point of Care Diagnostic and Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Point of Care Diagnostic and Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Point of Care Diagnostic and Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Point of Care Diagnostic and Testing Revenue Breakdown by Type (2018-2029)
3 Point of Care Diagnostic and Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Home
3.1.4 Others
3.2 Global Point of Care Diagnostic and Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Point of Care Diagnostic and Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Point of Care Diagnostic and Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Point of Care Diagnostic and Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Point of Care Diagnostic and Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Point of Care Diagnostic and Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Point of Care Diagnostic and Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Point of Care Diagnostic and Testing Revenue Breakdown by Application (2018-2029)
4 Point of Care Diagnostic and Testing Competition Analysis by Players
4.1 Global Point of Care Diagnostic and Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Point of Care Diagnostic and Testing as of 2022)
4.3 Date of Key Players Enter into Point of Care Diagnostic and Testing Market
4.4 Global Top Players Point of Care Diagnostic and Testing Headquarters and Area Served
4.5 Key Players Point of Care Diagnostic and Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Point of Care Diagnostic and Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 F. Hoffmann-La Roche
5.1.1 F. Hoffmann-La Roche Profile
5.1.2 F. Hoffmann-La Roche Main Business
5.1.3 F. Hoffmann-La Roche Point of Care Diagnostic and Testing Products, Services and Solutions
5.1.4 F. Hoffmann-La Roche Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.1.5 F. Hoffmann-La Roche Recent Developments
5.2 Qiagen
5.2.1 Qiagen Profile
5.2.2 Qiagen Main Business
5.2.3 Qiagen Point of Care Diagnostic and Testing Products, Services and Solutions
5.2.4 Qiagen Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Qiagen Recent Developments
5.3 Danaher
5.3.1 Danaher Profile
5.3.2 Danaher Main Business
5.3.3 Danaher Point of Care Diagnostic and Testing Products, Services and Solutions
5.3.4 Danaher Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Becton Dickinson and Company Recent Developments
5.4 Becton Dickinson and Company
5.4.1 Becton Dickinson and Company Profile
5.4.2 Becton Dickinson and Company Main Business
5.4.3 Becton Dickinson and Company Point of Care Diagnostic and Testing Products, Services and Solutions
5.4.4 Becton Dickinson and Company Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Becton Dickinson and Company Recent Developments
5.5 Biomerieux
5.5.1 Biomerieux Profile
5.5.2 Biomerieux Main Business
5.5.3 Biomerieux Point of Care Diagnostic and Testing Products, Services and Solutions
5.5.4 Biomerieux Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Biomerieux Recent Developments
5.6 Siemens Healthcare
5.6.1 Siemens Healthcare Profile
5.6.2 Siemens Healthcare Main Business
5.6.3 Siemens Healthcare Point of Care Diagnostic and Testing Products, Services and Solutions
5.6.4 Siemens Healthcare Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Siemens Healthcare Recent Developments
5.7 Zoetis
5.7.1 Zoetis Profile
5.7.2 Zoetis Main Business
5.7.3 Zoetis Point of Care Diagnostic and Testing Products, Services and Solutions
5.7.4 Zoetis Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Zoetis Recent Developments
5.8 Abbott
5.8.1 Abbott Profile
5.8.2 Abbott Main Business
5.8.3 Abbott Point of Care Diagnostic and Testing Products, Services and Solutions
5.8.4 Abbott Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Abbott Recent Developments
5.9 Bayer
5.9.1 Bayer Profile
5.9.2 Bayer Main Business
5.9.3 Bayer Point of Care Diagnostic and Testing Products, Services and Solutions
5.9.4 Bayer Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Bayer Recent Developments
5.10 Johnson and Johnson
5.10.1 Johnson and Johnson Profile
5.10.2 Johnson and Johnson Main Business
5.10.3 Johnson and Johnson Point of Care Diagnostic and Testing Products, Services and Solutions
5.10.4 Johnson and Johnson Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Johnson and Johnson Recent Developments
5.11 Nova Biomedical
5.11.1 Nova Biomedical Profile
5.11.2 Nova Biomedical Main Business
5.11.3 Nova Biomedical Point of Care Diagnostic and Testing Products, Services and Solutions
5.11.4 Nova Biomedical Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Nova Biomedical Recent Developments
5.12 Trividia Health
5.12.1 Trividia Health Profile
5.12.2 Trividia Health Main Business
5.12.3 Trividia Health Point of Care Diagnostic and Testing Products, Services and Solutions
5.12.4 Trividia Health Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Trividia Health Recent Developments
5.13 Quidel Corporation
5.13.1 Quidel Corporation Profile
5.13.2 Quidel Corporation Main Business
5.13.3 Quidel Corporation Point of Care Diagnostic and Testing Products, Services and Solutions
5.13.4 Quidel Corporation Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Quidel Corporation Recent Developments
5.14 Trinity Biotech
5.14.1 Trinity Biotech Profile
5.14.2 Trinity Biotech Main Business
5.14.3 Trinity Biotech Point of Care Diagnostic and Testing Products, Services and Solutions
5.14.4 Trinity Biotech Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Trinity Biotech Recent Developments
5.15 Sekisui Diagnostics
5.15.1 Sekisui Diagnostics Profile
5.15.2 Sekisui Diagnostics Main Business
5.15.3 Sekisui Diagnostics Point of Care Diagnostic and Testing Products, Services and Solutions
5.15.4 Sekisui Diagnostics Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.15.5 Sekisui Diagnostics Recent Developments
5.16 Orasure Technologies
5.16.1 Orasure Technologies Profile
5.16.2 Orasure Technologies Main Business
5.16.3 Orasure Technologies Point of Care Diagnostic and Testing Products, Services and Solutions
5.16.4 Orasure Technologies Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.16.5 Orasure Technologies Recent Developments
5.17 Nipro
5.17.1 Nipro Profile
5.17.2 Nipro Main Business
5.17.3 Nipro Point of Care Diagnostic and Testing Products, Services and Solutions
5.17.4 Nipro Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.17.5 Nipro Recent Developments
5.18 Spectral Medical
5.18.1 Spectral Medical Profile
5.18.2 Spectral Medical Main Business
5.18.3 Spectral Medical Point of Care Diagnostic and Testing Products, Services and Solutions
5.18.4 Spectral Medical Point of Care Diagnostic and Testing Revenue (US$ Million) & (2018-2023)
5.18.5 Spectral Medical Recent Developments
6 North America
6.1 North America Point of Care Diagnostic and Testing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Point of Care Diagnostic and Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Diagnostic and Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Point of Care Diagnostic and Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Diagnostic and Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Point of Care Diagnostic and Testing Market Dynamics
11.1 Point of Care Diagnostic and Testing Industry Trends
11.2 Point of Care Diagnostic and Testing Market Drivers
11.3 Point of Care Diagnostic and Testing Market Challenges
11.4 Point of Care Diagnostic and Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
